STANDARD BIOTOOLS INC. cotiza a 0.66 USD y tiene una capitalización bursátil de $259M. En los últimos 12 meses ha facturado $85M con un margen de flujo de caja libre del -96.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.06 | $-0.02 | $0.07 |
| Estimado | $-0.01 | $-0.03 | $-0.02 | $-0.02 |
| Sorpresa | — | -100.0% | +0.0% | +450.0% |
| Métrica | LAB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 49.9% | 57.0% | -7.2% |
| Operating Margin | -129.2% | -38.6% | -90.6% |
| Net Margin | -87.8% | -33.6% | -54.2% |
| FCF Margin | -96.8% | -13.9% | -83.0% |
| ROE | -17.6% | -40.4% | +22.8% |
| ROA | -13.2% | -32.0% | +18.8% |
| Current Ratio | 4.19 | 2.84 | +1.35 |
| Debt / Equity | — | 0.28 | — |